SHOULDER INNOVATIONS, INC. Other Noncash Income (Expense)
SHOULDER INNOVATIONS, INC. (SI) reported Other Noncash Income (Expense) of -$292.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. other noncash income (expense) for the quarter ending 2026-06-30 was -$172.00K.
- SHOULDER INNOVATIONS, INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$120.00K.
- SHOULDER INNOVATIONS, INC. other noncash income (expense) for the quarter ending 2025-12-31 was $166.00K, a 76.91% decline year-over-year.
- SHOULDER INNOVATIONS, INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$67.00K.
- SHOULDER INNOVATIONS, INC. other noncash income (expense) for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- SHOULDER INNOVATIONS, INC. other noncash income (expense) for fiscal 2024 was $571.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$292.00K 10-Q · filed 2026-08-06 | -$126.00K derived: sum of 3 quarters · filed 2026-08-06 | -$193.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$120.00K 10-Q · filed 2026-05-13 | $46.00K derived: sum of 2 quarters · filed 2026-05-13 | -$21.00K derived: sum of 3 quarters · filed 2026-05-13 | -$120.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $99.00K derived: sum of 2 quarters · filed 2026-03-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 10-K · filed 2026-03-10 |
| 2025-09-30 | -$67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$166.00K derived: sum of 2 quarters · filed 2026-08-06 | -$166.00K 10-Q · filed 2025-11-12 | $553.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$99.00K 10-Q · filed 2026-08-06 | $620.00K derived: sum of 3 quarters · filed 2026-08-06 | $606.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | $719.00K derived: sum of 2 quarters · filed 2026-05-13 | $705.00K derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $719.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $705.00K derived: sum of 2 quarters · filed 2026-03-10 | $571.00K 10-K · filed 2026-03-10 | |
| 2024-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$148.00K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$134.00K 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |